IL24 and neoplasm: Immunohistochemical (IHC) staining (Figure 4B) demonstrated that after the treatment with the combination of VV‐IL‐24 and luteolin, the IL‐24 protein was expressed in tumor tissue at a markedly higher level than in the other groups.